Insights

No items available

In the Spotlight

Safety and efficacy in immune-oncology – getting the balance right.

Attempting to harness the body’s adaptive defense system into a drug? In this post, discover different factors to consider when trying to strike the right balance between the safety and efficacy of your antibody.

An interview with Scientific Advisor Erika Fletcher

An interview with Scientific Advisor Erika Fletcher. To the clients she works with, Erika Fletcher’s sharp scientific mind is one of Immuneed’s strongest assets.

Simultaneous assessment of drug mechanisms and infusion reactions

New paper featuring Immuneed. Donor-specific immune effector signatures of CLL patients in response to anti-CD20.

The spark behind Immuneed. An interview with founder Sara Mangsbo.

The spark behind Immuneed. An interview with founder Sara Mangsbo.